GTCM
CNMD icon

Gyon Technologies Capital Management’s CONMED CNMD Stock Holding History

Gyon Technologies Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$443 – 102
2022
Q4 		$443 Buy
+5
New +$415 ﹤0.01% 466
2021
Q1 		– Sell
-3,518
Closed -$394K – 419
2020
Q4 		$394K Buy
+3,518
New +$333K 0.14% 207

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Gyon Technologies Capital Management's CNMD Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of CONMED (CNMD) in Q1 2023, closing a stake of 5 shares — an estimated $443 sold.

Gyon Technologies Capital Management first reported a position in CNMD in Q4 2020 and held it in 2 quarters. The position peaked at $394K in Q4 2020. 233 funds tracked by Wall St. Rank hold CNMD as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining CONMED position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 5 CONMED shares in Q1 2023, an estimated $443.
  • Gyon Technologies Capital Management first reported a position in CONMED in Q4 2020 and held it in 2 quarters.
  • Gyon Technologies Capital Management's CONMED position peaked at $394K in Q4 2020.
  • 233 funds tracked by Wall St. Rank held CONMED as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.